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Prions are self-perpetuating protein aggregates that cause neurodegenerative 
diseases in mammals and carry heritable traits in yeast. Yeast [PSI+] prion is the prion 
isoform of Sup35 protein, an essential translation termination factor. The [PSI
+
] prion 
state can be induced in [psi
-
] cells by the overexpression of the full-length Sup35 protein, 
or only a certain portion of the protein. However, this induction requires the presence of a 





] is present in lab cultures of S. cerevisiae, it has not been reported in 
any other Saccharomyces species. In this study, we attempted to induce [PSI
+
] in S. 
paradoxus and S. bayanus, two close relatives of S. cerevisiae. As non-cerevisiae species 
of Saccharomyces lack other known prions, we employed a new induction approach 
based on the overproduction of a chimeric protein composed of portions of Sup35 and 
Human Progesterone Receptor 6.6 (HPR6.6). This construct can induce [PSI
+
] in the 
absence of other endogenous prions. We next engineered S. paradoxus and S. bayanus 
strains with markers that allowed for prion studies in these species. The novel Sup35-
HPR6.6 fusion constructs led to [PSI
+
] induction in S. paradoxus, the sister species of S. 
cerevisiae, but not in the more distantly related S. bayanus. We also showed that the 
prion isoform of Sup35 from S. paradoxus, previously known to produce only unstable 
prions in the heterologous S. cerevisiae system, can generate mitotically stable prions in 
the homologous S. paradoxus system. Finally, we propose a model which explains the 









Prions are a novel type of infectious agents composed entirely of aggregated 
protein subunits. The apparent lack of nucleic acids-based replication distinguishes prions 
from all other living or virus-like elements known to date. Instead, prions propagate 
themselves by converting the normal cellular proteins of the same amino acid sequence to 
an aggregated form (PRUSINER 1998). These aggregates are characteristic of prion-caused 
diseases such as bovine spongiform encephalopathy (“mad cow” disease), sheep scrapie, 
human Creutzfeld-Jakob disease and kuru, and others. In addition, prion-like aggregates 
are found in several neurodegenerative diseases, including Alzheimer, Parkinson and 
Huntington diseases (TRZESNIEWSKA et al. 2004). Finally, prions are also present in 
several yeast species (WICKNER et al. 2007). 
[PSI
+
], one of several prions in the yeast Saccharomyces cerevisiae (SC), is 
formed upon the aggregation of the essential protein Sup35. The normal cellular function 
of Sup35 is termination of translation during protein synthesis. As a result of its dual 
roles in prion formation and translation termination, Sup 35 has two distinct domains 
with characterized function: a prion domain at its N-terminus (N domain or Sup35N), and 
a functional domain that carries out translation termination at the C-terminus (C domain 
or Sup35C). A third domain is located between the prion and functional domains. 
However, as its function is not yet known, it is simply referred to as the middle domain 
(M domain, or Sup35M) (Figure 1).  
Saccharomyces paradoxus (SP) and Saccharomyces bayanus (SB) are two close 
relatives of S. cerevisiae. The two species diverged from S. cerevisiae approximately 5-
20 million years ago, with S. paradoxus being a closer relative to S. cerevisiae than S. 
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bayanus (KAWAHARA and IMANISHI 2007) (Figure 2A). In addition, Sup35 is conserved 
in the three species, both in terms of overall structure and amino acid sequence (Figure 
2B). Despite the overall relatedness of the species, the [PSI+] prion has not yet been 
reported in S. paradoxus or S. bayanus.  
In this study, we created S. paradoxus and S. bayanus strains that allow prion 
studies in them. We then used a novel construct in an attempt to induce the prion state of 
Sup35 in S. paradoxus and S. bayanus and characterized any induced prions based on 
their stability, curability, and in vivo Sup35 solubility/aggregation patterns. 
 
3. LITERATURE REVIEW 
3.1. Discovery and Structure of Prions 
Scrapie, a wasting disease in sheep, has been known in Europe since the Middle 
Ages. Veterinary doctors were conducting studies on infected sheep as early as the 1950s. 
One of the first reviews of the novel heritability patterns of the disease appeared in 1960, 
but it failed to provide an explanation about the nature of the causative agent (PARRY 
1960). Amidst attempts to isolate and characterize the agent, Tikvah Alper proposed the 
radical idea that the cause of this infectious disease did not contain any nucleic acids. He 
based his claim upon the apparent high resistance of the infectious particle to ionizing 
and ultraviolet radiation, agents known to damage DNA and RNA (ALPER et al. 1967). 
Not surprisingly, Apler’s proposal was met with vehement outcry from the scientific 
community. Most researchers maintained their positions that the elusive particle was a 
slow-acting virus (ADAMS and CASPARY 1967). Despite the mounting evidence to the 
 5 
contrary, some scientists did not change their views even into the 1990s (BROWN and 
GAJDUSEK 1991).  
The first support for Apler’s hypothesis came from a surprising source. A 
mathematician, J.S. Griffith, used a mathematical proof to show that the scrapie agent 
could not only be a protein, but could also self-replicate (1967). He even went as far as to 
suggest that the elusive infectious agent was a normal cellular protein that adopted novel 
conformations (GRIFFITH 1967). Later, mostly biochemical, research revealed even more 
secrets of the confusing disease-causing particle. Treatment with nucleases, 
phospholipases and proteases seemingly did not affect the infectivity of the agent 
(PRUSINER et al. 1980). These results suggested that the agent could be composed of 
aggregated, highly stress-resistant proteins, which led Prusiner to finally propose the term 
‘prion’ in 1982 as an abbreviation for an ‘proteinatious infectious particle’ (PRUSINER 
1982). Soon thereafter researchers were able to find the previously hypothesized protein 
aggregates in the brains of scrapie-infected animals. Paul Bendheim and team were able 
to obtain antibodies to the prion protein, which they used to visualize the spread of the 
aggregates across the brain (BENDHEIM et al. 1984). In addition, the aggregates formed 
highly organized structures called “amyloid fibers” (DEARMOND et al. 1985). At about 
the same time, the prion world was starting to grow as prions were raised as the possible 
causative agents of bovine spongiform encephalopathy (“mad cow” disease) (HOLT and 
PHILLIPS 1988), and as explanations for the unexpected heritability patterns seen in yeast 
(COX et al. 1988).  
Major advances were being made in elucidating the precise structure and 
replication of prions as well. Analysis of initial prion aggregation with electron 
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microscopy and infrared spectroscopy revealed that the amyloid fibers were composed of 
α-helices and β-sheets (GASSET et al. 1992). It was later determined that the α-helices are 
a transient structure in the process of the conversion of normal cellular proteins into the 
insoluble, highly organized amyloids composed of β-sheets (PAN et al. 1993). The prions 
then replicated through the formation of infectious nuclei, or seeds, that catalyzed the 
conversion of the non-prion isoform of the protein into a prion (LANSBURY and CAUGHEY 
1995).  
 
3.2. Yeast Prions 
As in the case of mammalian prions, yeast prions were known long before their 
identity and properties were suspected. For example, ψ+/[PSI+] was a long-known extra-
chromosomal factor in the yeast Saccharomyces cerevisiae. In a 1988 review, Brian Cox, 
one of the main investigators working with [PSI
+
], summarized the existing evidence 
pointing to a novel mode of heritability, but did not make a connection with the already 
known mammalian prions (COX et al. 1988). Reed Wickner seems to be the first yeast 
scientist to notice the connection. While working with [URE3], another yeast element 
with puzzling heritability, he suggested that it has prion-like properties (WICKNER 1994). 
Later that same year, two independent labs reported in the same issue of Genetics that 
mutations in the SUP35 gene are responsible for the [PSI
+
] phenotype (DOEL et al. 1994), 
(TER-AVANESYAN et al. 1994). These two studies explained that certain mutations can 
make the protein less likely to form prions.  
A variety of factors can influence the presence and transmission of the [PSI
+
] 
prion. For example, chaperone proteins normally involved in stress responses are 
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intricately involved in prion induction and transmission. In addition, different chaperone 
families can have different effects on induction and transmission (NEWNAM et al. 1999).  
Another important factor is the presence of an additional yeast prion called 
[PIN
+
], the prion isoform of Rnq1 protein. In the absence of the [PIN
+
] prion, de novo 
[PSI
+
] prion induction is rarely observed (DERKATCH et al. 1997), (BORCHSENIUS et al. 
2002). It is likely that [PIN
+
] interacts with soluble Sup35 to provide a scaffold on which 
the prion conversion of Sup35 can occur (Figure 3). However, certain amino acid 
sequences can help overcome the [PIN
+
] requirement (DERKATCH et al. 2000).  
Finally, a fortunate discovery led to the identification of guanidine hydrochloride 
(GuHCl), a chemical compound that can cure yeast prions (TUITE et al. 1981), and is thus 
used as a defining feature of whether something is a prion. The mechanism of action of 
GuHCl probably involves the inactivation of one of the chaperone proteins that are 
involved in prion propagation (FERREIRA et al. 2001). 
 
3.3. Species Barrier in Prion Transmission 
In order to facilitate prion research, scientists tried to create a mouse model of 
prion infections. However, they noticed that transmission of sheep scrapie to mice was 
decreased as compared to transmission within the same species, giving rise to the so 
called “species barrier” phenomenon. Lansbury and Caughey tried to explain the 
existence of the species barrier by proposing that the interacting proteins between 
different species contained amino acid substitutions that made aggregate formation less 
favorable (1995). Experiments that have been carried out with yeast prions seemed to 
support Lansbury and Caughley’s hypothesis: prion proteins from highly divergent 
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species did not co-aggregate (SANTOSO et al. 2000). However, studies with mammalian 
prions showed that binding was not significantly affected despite the sequence 
divergence between the interacting proteins, but prion conversion was inhibited 
(HORIUCHI et al. 2000). A recent study carried out in yeast supported the latter theory 
about the role of aggregation. Specifically, Chen et al. showed that proteins from closely-
related species co-aggregated, but there was no prion conversion (2007). Thus, they 
proposed that there could be different mechanisms for the species barrier. While prions 
from divergent species do not co-aggregate, the species barrier between closely related 
species is controlled at the level of aggregate conformation instead of binding.  
 
3.4. Prion Strains 
The presence of different prion isoforms coming from the same protein and amino 
acid sequence have been known since the early 1990s. For example, different strains 
(also called isolates or variants) of mammalian prions have different brain distribution 
and infection patterns. Still, the pattern of each individual strain is highly reproducible 
(DEARMOND et al. 1993). The same effect is observed in yeast: the same protein can give 
rise to multiple strains upon conversion into a prion, both for the [PSI+] (DERKATCH et al. 
1996) and [URE3] prions (SCHLUMPBERGER et al. 2001). The likely cause is that various 
conformations can be formed in the initial steps of prion conversion. Each conformation 
can then “seed” a different strain of prion proteins (CHIEN and WEISSMAN 2001). Work 
done by Uptain et al. clarifies that the strains also differ in terms of ratios of aggregated 
to non-aggregated proteins (2001). The authors also suggest that different conformations 
are more thermodynamically favored than others, which explains the different protein 
 9 
ratios. The favored conformations of yeast prions can propagate better and are called 
“strong” strains; the less favored conformations are weaker and harder to transmit and are 
called “weak” strains.  
 
3.5. Ways to Study Prions 
While a large number of techniques are available for the detection and analysis of 
both mammalian and yeast prions, only a few of them are relevant for this study. These 
include widely-used methods applied to yeast prions, including detection with a nonsense 
suppression assay, de novo prion induction, and differential centrifugation. The reader is 
referred to a review by Chernoff et al. for a more exhaustive information on several 
additional methods (2002).  
 
3.5.1. [PSI+] Prion Detection 
Because Sup35 is a translation termination protein, factors that decrease its 
function also increase the read-through of stop codons, including premature ones. The 
presence of [PSI
+
] in yeast cells could be detected as early as 1983 if the cells contained 
an ADE2 allele (part of the adenine biosynthetic pathway) that contained a premature 
UGA codon (TUITE et al. 1983). A number of other alleles have the same effect. For 
example, the ade1-14 allele, also involved in the adenine pathway, contains a premature 
UGA stop codon as well (NEWNAM et al. 1999). In [psi
-
], prion-free cells, Sup35 is 
functional, stops translation at the UGA codon, which results in a truncated Ade1 protein. 
The truncated version of Ade1 is nonfunctional, making cells unable to grow on media 
lacking adenine (-Ade media). In addition, a red precursor accumulates in the cells, 
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giving rise to red colonies when they are grown on YPD (rich yeast medium). However, 
if Sup35 is in its aggregated [PSI+] form, it cannot carry out its function completely and 
there is a readthrough of the stop codons, allowing the strain to grow on media lacking 
adenine (CHERNOFF et al. 2002). Thus, this suppression of translation termination 
resulting in growth can be used to detect prions (Figure 4). In this study, we used strains 
containing only the ade1-14 allele as a reporter for the presence of prions. 
 
3.5.2. Differential Centrifugation 
The aggregation of Sup35 in [PSI
+
] strains changes the solubility of the protein. 
This change can be detected by a differential centrifugation assay. Sup35 in [PSI+] can be 
pelleted by centrifugation at 12,000 g, while Sup35 in [psi-] cells remains mostly soluble 
even at 100,000 g. The different solubility patterns can be visualized by performing 
Western blotting on both the pellets and supernatants after centrifugation with an 
antibody against Sup35 (PATINO et al. 1996).  
 
3.5.3. Prion Induction 
One possible way to introduce prions to cells is to infect the cells, for example by 
mating [psi-] haploids to [PSI+] strains. Still, it is also possible to induce de novo prion 
formation by the overexpression of either the full-length prion protein (DERKATCH et al. 
1996), or only portions that include the prion domain (GLOVER et al. 1997), 
(BORCHSENIUS et al. 2002). However, induction of [PSI
+
] using both of these methods 
requires the presence of the [PIN
+
] (BORCHSENIUS et al. 2002). The [PIN
+
] requirement 
can be overcome by the addition of a short extension of 16 amino acids to Sup35NM 
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(DERKATCH et al. 2000). Another extension with the same effect is a portion of the 
Human Progesterone Receptor protein 6.6 (HPR6.6). The Sup35NM-HPR6.6 fusion 
construct efficiently induces [PSI+] in a [PIN+]-independent manner (Chernoff lab, 
unpublished data).  
In this study, we used the above-mentioned construct as an inducer for [PSI
+
]. In 
particular, Sup35NM from S. cerevisiae, S. paradoxus and S. bayanus were used to create 
three possible inducers: Sup35NMSC-HPR6.6, Sup35NMSP-HPR6.6 and Sup35NMSB-
HPR6.6. The inducers were on plasmids under the CUP1 copper-inducible promoter, 
allowing for their overexpression. Each of the three plasmids was transformed into each 
of the three species. Furthermore, S. cerevisiae and S. bayanus contained chromosomal 
sup35 deletions, and the essential gene was replaced by plasmids containing the full-
length SUP35 gene from one of the three species. Thus, even within one species, there 
were nine combinations of an HPR6.6-fusion construct and full-length protein. The S. 
paradoxus strain used for this study contained its wild-type copy of SUP35, but was still 
transformed with the three inducers. 
 
3.6. Implications of Current Study 
The findings from the study show whether the cell environment or the intrinsic 
properties of the Sup35 protein are responsible for its prion-forming abilities. 
Furthermore, because the inducers and full-length proteins will be from different species, 
the study represents another test for the model that was proposed to explain the species 




4. MATERIALS AND METHODS 
4.1. Genetic and Microbiological Techniques 
4.1.1. Yeast Strains and Maintenance 
Standard growth media were used for the maintenance of yeast strains as 
described previously (SHERMAN 2002). As needed, additional chemicals were added at 
the concentrations indicated below. 
All S. cerevisiae strains were isolates of the strain GT671 (MATα ade1-14 his3∆ 





but containing different plasmids (Table 1). S. cerevisiae strains were grown and 
incubated at 30ºC unless otherwise specified (e.g, heat shock).  





]), originally derived from SP7-1D (CHEN et al. 2007). All S. 
bayanus strains are derivatives of Su1A (MATa ura3-1 ho::KanMX4) (TALAREK et al. 2004) 
S. paradoxus and S. bayanus strains were maintained and manipulated at 25ºC unless 
otherwise specified. 
Information about all strains used in this study can be found in Table 1. Table 2 
contains descriptions of all primers used in strain creation. In addition, Figure 5 shows a 
graphic representation of the regions that primers for ADE1 cover.  
 
4.1.2. Plasmid Creation and Transformation in E. coli 
Shuffle plasmids containing both bacterial and yeast genetic markers were created 
using a Quick Ligation™ Kit (New England Biolabs, Inc. Beverly, MA), following the 
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manufacturer’s protocol, with the exception that the cells were heat shocked at 42ºC, 
instead of 37ºC. All plasmids used in this study are described in Table 3.  
 
4.1.3. Yeast Genomic DNA Isolation and PCR 
In order to isolate their genomic DNA, yeast cells were grown overnight in 10mL 
of liquid YPD. The cells were then pelleted at 2500rpm for 5 min, resuspended in 0.5mL 
of 1M sorbitol, 0.1M NaEDTA (pH 7.5), and transfered to a 1.5mL microcentrifuge tube. 
40µL of 4mg/mL solution of lyticase was added, and the cells were incubated overnight 
in a 37ºC water bath. After pelleting at 3000rpm for 5min, the supernatant was removed, 
the cells were resuspended in 0.5mL of a 50mM Tris-Cl (pH 7.4), 20mM NaEDTA 
solution, and treated with 55µL of 10% SDS. Following incubation at 65ºC for 30min, 
0.2mL of 5M potassium acetate was added, and the cells were left on ice for one hour. 
Cell debris was separated from the DNA by high speed centrifugation. The supernatant 
was transferred to another microcentrifuge tube, and DNA was precipitated with 0.75mL 
of isopropanol at -20ºC for 30 min. The DNA was later pelleted, washed with 70% 
ethanol, dried, and resuspended in 0.4mL of a 10mM Tris-Cl (pH 7.4), 1mM NaEDTA 
solution (1X TE). Any residual RNA was removed by treatment with 2.2µL of 10mg/mL 
solution of RNase A at 37ºC for 30 min. The remaining DNA was precipitated with 
0.84mL of 95% ethanol at -20ºC for 30 min. Finally, the DNA was collected, washed, 
dried and resuspended in 50µL of 1X TE.  
When needed, approximately 100ng of the genomic DNA was used for each PCR 
sample. The samples also contained 5µL of ThermoPol Buffer, 4µL of 10µM dNTPs, 1µL 
of 50mM for each forward and reverse primer, and 1000 units of either Taq or Deep Vent 
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polymerases. De-ionized water was used to adjust the final volume to 50µL. The reaction 
was carried our in Bio-Rad iCycler (Bio-Rad Laboratories, Hercules, CA) for 35 cycles 
and conditions appropriate for each primer set.  
 
4.1.4. Yeast Transformation 
To prepare yeast cells for plasmid transformations, the cells were grown overnight 
in 10mL liquid YPD. An equal volume of YPD was then added, and the cells were 
allowed to grow for 3-4 more hours to reach OD600 of approximately 2. The cells were 
collected by centrifugation for 5 min at 3000 rpm, washed with 10mL of 1X TE, and 
resuspended in 10mL of a 100mM LiAc, 10mM Tris-HCl, 1mM EDTA pH8.0 solution. 
After incubation for 60 minutes, the cells were collected and concentrated by 
resuspending them in 0.5mL of the same solution. 50µL of yeast cells were used for each 
transformation reaction. The reactions also contained approximately 20µg of carrier DNA 
and 1µg of transforming DNA (plasmid or PCR product). After incubating the reactions 
for 30min, 350µL of a 100mM LiAc, 40% PEG 4000, 10mM Tris-HCl, 1mM EDTA 
pH8.0 solution was added and the cells were incubated for an additional hour. Finally, the 
cells were heat shocked at 42ºC for 7 min and plated on the appropriate solid medium. 
 
4.1.5. Yeast Sporulation and Dissection 
Yeast cells to be dissected were grown on pre-SPO media containing any amino 
acids necessary for growth for one day, replica-plated to SPO media with the necessary 
amino acids, and allowed to grow for five days. A small patch of cells was dissolved in 
40µL of 4mg/mL solution of lyticase, mixed well by vortexing, and incubated at 37ºC for 
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10 min. The cells were collected by centrifugation at 14,000 rpm for 10 min and 
resuspended in 20µL of water. A small amount of the cell solution was spotted into 
dissection media and dissected using a Singer MSM 300 micromanipulator according to 
the manufacturer’s instructions.  
 
4.2. Prion Induction by Overexpression of Sup35NM 
The sup35∆ strains of S. bayanus and S. cerevisiae and the SUP35 strain of S. 
paradoxus were transformed with the HPR6.6-fusion constructs described above. 12 
individual transformants were checked for each possible combination. The transformants 
were then replica-plated to media containing 10, 25, 50 or 100µM of CuSO4 to 
overexpress the inducers. After 1-2 days on copper-containing medium, the transformants 
were replica-plated to media lacking adenine. If [PSI
+
] induction occurred, it could be 
detected at approximately day 7 of incubation.  
 
4.3. Characterization of Prions 
4.3.1. Mitotic Stability of Prions 
To check prion stability, colonies containing induced prions were streaked out for 
single colonies on YPD medium. Each streak-out gave rise to approximately 100-200 
mitotic derivatives of each starting colony. Stable prions gave rise to colonies of mostly 





4.3.2. Prion Curability 
Prion-containing colonies were spotted on YPD medium containing 50µM 
GuHCl. The plates were incubated overnight and then a new spot was made on the same 
plate using the spot made the previous day. The procedure was repeated one more time 
for overall three passages on GuHCl media. The third spot was streaked out for single 
colonies, and four colonies from each spot were checked for growth on media lacking 
adenine. Colonies passed only through YPD were used as a control. Cured colonies did 
not grow on media lacking adenine. 
 
4.3.3. Protein Isolation and Differential Centrifugation 
In order to isolate proteins from yeast cells, the cultures were grown overnight in 
10mL YPD. On the next day, the cultures were incubated with 200µg/mL cyclohexamide 
for 20 min. The cells were collected by centrifugation and washed and resuspended in 
lysis buffer (25nM Tris pH 7.5, 100mM NaCl, 1nM DTT, 10mM EDTA, 2nM PMSF, 
10% cOmplete Protease Inhibitors Cocktail (Roche Applied Sciences, Indianapolis, IN)). 
The cells were then lysed by vortexing for 90s with an equal volume of glass beads. Half 
of the total cell lysate was centrifuged for 15 min at 10,000 g in a microcentrifuge for 
Sup35 protein or 30 min at 53,000 g in a Beckman Coulter OptimaTM MAX 
untracentrifuge for Rnq1 protein in order to separate aggregated from non-aggregated 
proteins. The supernatant, containing the soluble proteins, was moved to another 
eppendorf tube and the pellet with the aggregated proteins was resuspended in an equal 




4.4. Western Blotting 
The total lysate, supernatant, and pellet obtained by differential centrifugation 
were run on an 8% polyacrylamide separating gel with a 5% stacking gel. The proteins 
were transferred to a Hybond™ ECL™ nitrocellulose membrane (GE Healthcare, 
Piscataway, NJ) using a Bio-Rad Trans-Blot
®
 sD Semi-Dry Transfer Cell (Bio-Rad 
Laboratories, Hercules, CA). The membrane was blocked overnight with a 5% non-fat 
milk solution, and washed three times with 1X TBS, 0.1% Tween for 15min each. A 
primary rabbit anti-Sup35NM or anti-Rnq1 antibody was then applied for 90 min at a 
1:2000 (v/v) dilution for Sup35 and a 1:5000 (v/v) dilution for Rnq1. After three more 
washes, the membrane was incubated with a secondary rabbit HRP antibody for 45 min 
at a 1:2000 (v/v) dilution for Sup35NM and a 1:3000 (v/v) dilution for Rnq1. Finally, 
following three more washes, the membrane was developed.   
 
5. RESULTS 
5.1. Strain creation for S. paradoxus and S. bayanus 
In order to use the nonsense suppression assay for [PSI+] detection in S. 
paradoxus and S. bayanus, the ade1-14 allele had to be introduced in these two species. 
The introduction was achieved by first replacing the species’ wild-type ADE1 genes with 
URA3 from S. cerevisiae (Figure 6A). The Ade
-
 strains were then transformed with a 
PCR-amplified ade1-14SC fragment. For S. bayanus, the ade1-14 fragment contained 40 
base pairs on each side of the open reading frame (ORF) to facilitate homologous 
recombination (Figure 5A). The fragment was then transformed into GT986 (MATa 
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ura3-1 ade1::URA3SC ho::KanMX4). Potential transformants were screened by growth on 
synthetic medium containing 1mg/mL of 5-fluoroorotic acid (5-FOA) to select for URA3 
mutants. A total of 24 Colonies showed growth on 5-FOA, and were checked by PCR 
and sequencing. Two Ura
-
 potentials had replacement of URA3 with ade1-14SC (Figure 
6C). After sequencing with a variety of primers (Figure 5A), one of the potentials 
contained the correct ade1-14SC sequence, and was saved as GT1038 (MATa ura3-1 
ade1::ade1-14SC ho::KanMX4).  
For the S. paradoxus construction, ade1-14 was first amplified with 40 base pairs 
on each side of the open reading frame (Figure 6B). A second set of primers used the 
product of the first PCR as a template to introduce 80 more base pairs homologous 
specifically to the promoter and terminator regions of ADE1 in S. paradoxus (Figure 5B). 
The scheme outlined for S. bayanus was then followed by transforming the ade1-14 PCR 





A total of 22 potentials had the URA3SC::ade1-14SC replacement (Figure 6C), but only 
five showed actual non-sense suppression in S. paradoxus.  Two of these five potentials 
were not sequenced, one showed the correct ade1-14SC sequence, and two had PCR-
generated errors. A strain containing ade1-14SC with two PCR-generated errors (GT1142: 
MATa ura3-P2 lys2 ∆ho::KanMX6 ade1SP::ade1-14SC (G277N, V278I) [psi
-] [pin-]) was 
used for induction experiments in S. paradoxus (Figure 6D).  
To obtain the sup35∆ strain of S. bayanus, a diploid was first obtained by mating 
GT1020 (MATα ura3-1 ho::KanMX4 lys2) and GT1028 (MATa ura3-1 ade1::ade1-14SC 
ho::KanMX4). The diploid was selected on media lacking lysine and uracil, and 
transformed with a PCR-amplified gene for resistance against the antibiotic ClonNAT. 
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The diploids were then transformed with a plasmid containing Sup35, sporulated and 
dissected. All spores were checked for growth on YPD+100mg/mL ClonNAT (from 
Werner BioAgents, Jena, Germany) and media lacking uracil, lysine or adenine. One 
spore that did grow on YPD+100mg/mL ClonNAT, but not on media lacking uracil, 
lysine or adenine, was saved as GT1122-2B (MATα sup35∆::ClonNAT ura3-1 lys2 
ade1::ade1-14SC). Strains containing Sup35 plasmids from all three species were 
obtained from this parental strain.  
 
5.2. S. paradoxus and S. bayanus are [pin-] 
Because of the importance of [PIN+] prion in [PSI+] induction, S. paradoxus and 
S. bayanus were checked for the presence of [PIN+] by differential centrifugation (Figure 




] were used as positive and 
negative control, respectively. It is clear that all of the Rnq1 protein, the determinant of 
[PIN
+
], is aggregated and thus found in the pellet of [PIN
+
] strains. In contrast, the great 
majority of Rnq1 is found in the supernatant of [pin
-
] cells because the protein is still 
soluble. The distribution of Rnq1 protein in S. paradoxus and S. bayanus is similar to the 
distribution in [pin-] S. cerevisiae: the majority of the protein is soluble and detected in 
the supernatant (Figure 7). Thus, the S. paradoxus and S. bayanus strains tested in this 




5.3. Sup35NM-fusion constructs 
Human Progesterone Receptor 6.6 (HPR6.6) is a human nuclear receptor. When 
part of it is fused to the C-terminus of Sup35NM (Sup35NM-HPR6.6), the construct is 
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capable of inducing [PSI
+
] in S. cerevisiae strains. In order to investigate the possibility 
that the Sup35NM-HPR6.6 constructs can induce [PSI+] in [pin-] background of S. 
paradoxus and S. bayanus as well, we created expression constructs where the chimeric 
protein was under the control of the CUP1 copper-inducible promoter (Figure 8A, B). 
The fusion proteins were expressed from a shuffle plasmid with URA3 yeast marker 
(Figure 8C).  
 
5.4. [PSI+] induction in sup35∆ [pin-] S. cerevisiae and S. bayanus  
S. cerevisiae strains containing Sup35SC, Sup35SP or Sup35SB expressed from a 
plasmid were transformed with each of six possible [PSI+] inducers: Sup35NMSC, 
Sup35NMSC-HPR6.6, Sup35NMSP-HPR6.6, Sup35NMSB-HPR6.6, Sup35NMSP-GFP 
(green fluorescent protein), and Sup35NMSB-GFP (Figure 9A), all expressed from 
copper-inducible promoters. Upon induction with copper-containing medium, the strains 
were checked for the presence of prion by growing them on media lacking adenine. For 
all three full-length genes, [PSI
+
] was induced by the homologous inducer containing 
Sup35NM from the same species (Figure 9A). However, the induction for Sup35SP with 
Sup35NMSP-HPR6.6 was much lower than the induction for the other two homologous 
combinations. Interestingly, Sup35SC could be induced into [PSI
+] by Sup35NMSP-
HPR6.6 and Sup35NMSB-HPR6.6 as well (Figure 9A). Heterologous induction was not 
observed in any other combination. In addition, Sup35NM only or Sup35NM fusions 
with a different extension (e.g. GFP) could not induce [PSI
+
] in the [pin
-
] S. cerevisiae 
cells. 
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S. bayanus strains containing Sup35SC, Sup35SP or Sup35SB expressed from a 
plasmid were also used for induction experiments. This time, only Sup35NMSC-HPR6.6 
Sup35NMSP-HPR6.6 and Sup35NMSB-HPR6.6 were used as inducers. Moreover, a 
control group contained the three full-length proteins in strains without any expressed 
inducers (Figure 9B). Unlike in S. cerevisiae, no prion induction was observed in S. 
bayanus. 
To determine whether the lack of induction in S. bayanus was caused by lack of 
expression of the inducers, the protein levels of the inducers were detected with Western 
blot. In S. cerevisiae cells where induction occurs, the expression of Sup35NMSC-HPR6.6 
inducer increased significantly after incubation on media containing 25µM copper as 
compared to copper-free media and the full-length Sup3 protein (Figure 10). The increase 
between 25 and 100µM was not as big as between 0 and 25µM. Sup35NMSC-HPR6.6 and 
Sup35NMSB-HPR6.6 were detected in S. bayanus after incubation with 25µM of copper 
because higher concentrations of copper were toxic to the cells, but it could not be 
determined if they were overexpressed as data for full-length Sup35 was not always 
available (Figure 10).   
 
5.5. [PSI+] Induction in S. paradoxus 
Unlike the S. cerevisiae and S. bayanus strains, the S. paradoxus strain available 
for this study did not contain chromosomal sup35 deletion. As a result, we could not 
follow the above-described induction strategy. Instead, the three possible inducers were 
used only on the full-length Sup35SP expressed from the chromosomal gene. The full-
length protein showed induction resembling the one exhibited by the full-length Sup35SC 
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in the S. cerevisiae cell environment: induction was possible with both the Sup35NMSC-
HPR6.6 and Sup35NMSP-HPR6.6 construct. However, in S. paradoxus, induction was 
not possible with the Sup35NMSB-HPR6.6 inducer (Figure 11). Interestingly, it seems 
that the heterologous Sup35NMSC-HPR6.6 induced the [PSI
+
] conversion of Sup35SP 
better that the homologous Sup35NMSP-HPR6.6 inducer.  
The phenotypic detection of [PSI
+
] by growth on media lacking adenine provides 
only an indirect support for the presence of prions inside cells. Thus, we directly checked 
whether prions were seen in cells by looking at protein aggregation patterns in Ade
-
 S. 
paradoxus strains before induction and in an Ade
+
 strain after induction and loss of the 
plasmid expressing the Sup35NMSP-HPR6.6 inducer. While Sup35 proteins were not 
detected in the pellet of Ade- cells, a large proportion of Sup35 was pelleted in Ade+ cells 
(Figure 12), confirming the presence of prions in S. paradoxus. 
 
5.6. Role of the Cell Environment in the Stability and Strength of Prions 
After induction, the plasmids containing the Sup35NM-HPR6.6 fusion constructs 
were lost by the cells after growth on non-selective media. Then, the stability, curability 
and strength of the putative prions were assessed. Curability generally correlated very 
well with stability: stable [PSI+] colonies were very curable by guanidine hydrochloride 
(data not shown). Unstable [PSI
+
] were also curable, but not with as high efficiency as 
the stable prion variants. 
The cell environment appeared to play a role on the stability of prions. For 
example, Sup35 from S. paradoxus formed unstable prions when induced in S. cerevisiae, 
but it formed both stable and unstable prions in its native S. paradoxus environment 
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(Table 4). Prions induced from Sup35SP were present in both strong and weak variants in 
both S. cerevisiae and S. paradoxus.  
Similar comparisons could not be performed for Sup35 from S. bayanus because 
it could be induced only in S. cerevisiae, where it existed only as weak and unstable prion 
variants (Table 4).  
 
6. DISCUSSION 
6.1. Fusion of Part of the Human Progesterone Receptor 6.6 (HPR6.6) Protein to 
Sup35 Induces [PSI
+
] without the Presence of Other Known Prions 
In this study, we used a novel Sup35-fusion construct to induce the [PSI+] prion 
isoform of Sup35 in S. paradoxus and S. bayanus. The construct contained part of the 
Human Progesterone Receptor 6.6 (HPR6.6), fused to Sup35NM domains, and expressed 
under a copper-inducible promoter (Figure 8). We showed that the construct successfully 
induced [PSI
+
] in the [pin
-
] S. paradoxus (Figures 7 and 11), but induction in S. bayanus 
was not detected (Figure 9B). The induction is specific to the addition of the HPR6.6 
extension, as Sup35NM by itself or with another extension could not induce [PSI
+
] in the 
[pin-] strains (Figure 9A). Our study represents only the second instance when induction 
was possible without the presence of a second yeast prion. However, in the other case, 
only a short amino acid stretch was responsible for the observed [PIN
+
]-independence 
(DERKATCH et al. 2000).  
Since the portion of HPR6.6 used in this study is highly hydrophobic, it is 
possible that it can spontaneously aggregate in order to decrease its surface area exposed 
to the cytoplasm. If the prion domain of Sup35 is predisposed to aggregation, aggregation 
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and prion conversion could be much faster when it is fused to HPR6.6 than when the 
protein is not. The Sup35NM-HPR6.6 might form a “prion-like” state that later helps 
with the prion conversion of full-length Sup35 (Figure 13). In this way, the HPR6.6 




] induction and thus help overcome the 
[PIN
+
] requirement.  
 
6.2. [PSI+] Prion Can Exist in Saccharomyces Species Other than S. cerevisiae  
While prions are not a property of S. cerevisiae only, [PSI
+
] prion has not been 
reported in other species within the Saccharomyces genera. Here, we report that [PSI
+
] 
can exist in at least one other Saccharomyces species: S. paradoxus (Figures 11, 12). We 
showed that the lack of induction in S. bayanus was not caused by the lack of expression 
of the inducer (Figure 10). However, it is possible that the ade1-14 reporter assay does 
not work in S. bayanus as in S. cerevisiae and S. paradoxus, so the lack of observed 
induction could be simply a lack of detection of induction. Indeed, only 5 of 22 ade1-14 
strains of S. paradoxus showed the nonsense suppression phenotype of the allele 
characteristic for [PSI
+
] S. cerevisiae. Thus, it is very likely that the ade1-14 alleles in the 
two ade1-14 strains of S. bayanus are not functional in the nonsense suppression assay. 
This possibility can be checked, for example, by differential centrifugation assay after 
induction in S. bayanus.  
Discrimination in prion formation between different species has been observed 
before. For example, Ure2 protein from S. bayanus is capable of forming the [URE3] 
prion in both S. cerevisiae and S. bayanus. In contrast, Ure2 from S. paradoxus cannot 
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adopt the prion conformation neither in S. cerevisiae, nor in S. paradoxus (BAUDIN-
BAILLIEU et al. 2003), (TALAREK et al. 2005).  
Our results also indicate that both the cell environment and intrinsic protein 
properties seem to play a role in prion formation. On one hand, Sup35 protein from S. 
cerevisiae can exist as a prion both in S. cerevisiae and S. paradoxus, indication that 
prion formation is something intrinsic to the protein. On the other hand, if the Sup35 
protein indeed cannot be induced into a prion in S. bayanus, it will mean that there is 
something different in this species when compared to S. cerevisiae and S. paradoxus. One 
possible explanation is that S. bayanus could contain some factors that inhibit the 
conversion between the normal and prion isoforms of the protein. The other possibility is 
that there could be factors in S. cerevisiae and S. paradoxus, other than known prions, 
that are essential for catalyzing the prion conversion of the normal cell protein.  
It is important to note that both explanations for the role of the cell environment 
evoke the existence of additional cell factors. The identification of these factors could be 
important in prion studies, especially if they elucidate the mechanism by which a normal 
cell protein can switch conformations and aggregate. Even more important, these factors 
could be conserved in humans and could have an effect in aggregate formation in the 
brains of patients with neurodegenerative diseases.  
The cell environment also plays a role in the stability of prions. From the studies 
of [PSI
+
] prion formed by the conversion of Sup35SP in both S. cerevisiae and S. 
paradoxus, it seems that prion conversion in the homologous cell environment is 
preferred and gives rise to more stable prion variants. Still, the successful prion induction 
in more species is required to confirm this generalization.  
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6.3. The Species Barrier in Prion Transmission Could be Controlled at the Level 
of Prion Induction  
Prion induction in S. bayanus notwithstanding, the induction of the full-length 
Sup35 protein by a homologous inducer was always possible, but the heterologous 
induction was rarer. This induction outcome was not surprising because the inducers 
contain the N region of Sup35: the prion domain of the protein that causes the species 
barrier in the Saccharomyces genera (CHEN et al. 2007). Extrapolating the findings to the 
interactions of two full-length divergent proteins, one of them would not be able to cause 
the prion conversion of the other. Thus, there will be no prions that can be passed on to 
daughter cells, explaining the species barrier.  
The rare heterologous induction can be explained if we consider that Sup35NMSC 
and Sup35NMSP give rise to prion aggregates with slightly different conformations. Each 
conformation will be more likely to seed the prion conversion of its homologous full-
length protein, but heterologous conversion will not be completely impossible. 
 
7. CONCLUSIONS 




• Sup35NM constructs containing part of the Human Progesterone Receptor 6.6 
(HPR6.6) protein can induce S. paradoxus and S. bayanus Sup35 proteins into 
prions without the presence of other known endogenous prions 
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• S. paradoxus Sup35 protein can be induced into a prion state in S. paradoxus 
cells, thus demonstrating that ability to form a prion is not a unique property of S. 
cerevisiae Sup35 protein 
• No prion formation by Sup35 protein was detected in S. bayanus 
• Mitotically stable prion variants of S. paradoxus Sup35, not detected in the 
heterologous (S. cerevisiae) cell environment, can be generated in the 
homologous (S. paradoxus) environment 
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9. APPENDIX A: FIGURES 
 
 
Figure 1. Structure of Sup35 protein. The prion forming domain, Sup35N, is located at the amino-terminus 
of the protein, while the region at the carboxy-terminus is the functional Sup35C. Sup35M is between the 
Sup35N and Sup35C domains. The numbers above the domains correspond to the amino acid positions 



















Figure 2. Experimental system. A. Species in the Saccharomyces genera used in the current study. 
Experiments were carried out in S. cerevisiae, S. paradoxus and S. bayanus. The numbers within the 
phylogenetic tree represent the divergence time between the different species in millions of years (Myr). B. 
Sup35 in the Saccharomyces genera. The overall structure of Sup35 is the same in S. cerevisiae (Sup35SC), 
S. paradoxus (Sup35SP) and S. bayanus (Sup35SB). The numbers above the different regions show the 
amino acid sequence identity as compared to the amino acid sequence of Sup35 in S. cerevisiae. Sup35 
from S. bayanus is missing nine amino acids, so the protein is a little shorter than the S. cerevisiae and S. 












Figure 3. A model for the role of [PIN
+
] prion in [PSI
+
] induction. When Rnq1 protein is in its aggregated, 
[PIN
+
] prion isoform, it could act as a scaffold where Sup35 can bind and undergo the conformational 
change required for its conversion from non-prion, [psi
-
], isoform to prion [PSI
+
] isoform. After the prion 

















Figure 4. Nonsense suppression assay used to detect [PSI
+
] prion. The cells contain a reporter ade1-14 
allele with a premature UGA stop codon in the ADE1 gene. A. In prion-free, [psi
-
], cells, Sup35 is 
completely functional, leading to a truncated Ade1 protein, and making cells unable to grow on media 
lacking adenine (-Ade media). B.  In [PSI
+
] cells, Sup35 is in an aggregated, partially inactive state, the 













Figure 5. Binding sites for primers associated with ade1-14 strain creation for S. bayanus (A) and S. 
paradoxus (B). The arrows show the direction of the primers. The numbers above ADE1 correspond to the 
binding positions of the primers. Not all primers bind directly to the chromosomal ADE1. See Table 2 and 
text for detail descriptions of the primers. 
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Figure 6. Introduction of the ade1-14 reporter allele in S. paradoxus and S. bayanus. A. Approach for the 
replacement of ADE1 in S. bayanus with ade1-14 from S. cerevisiae. ADE1 (approximate size of 0.9kb) in 
S paradoxus and S. bayanus was first replaced by a PCR-amplified copy of URA3 (approximate size of 
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1.2kb) from S. cerevisiae by transformation. Then, URA3 was replaced with the PCR-amplified ade1-14 
from S. cerevisiae by a second transformation. All genes were amplified with 40bp outside of the open 
reading frame (ORF) to facilitate homologous recombination. B. Modified approach for ade1-14 
introduction in S. paradoxus. The basic sequence of steps was the same as the replacement in S. bayanus. 
However, after ade1-14 was amplified from S. cerevisiae with 40bp outside of the ORF, a second set of 
primers was used to introduce longer homologous region to S. paradoxus.  The second set of primers was 
100bp long, with 20bp overlapping with the original primers. The other 80bp contained sequence 
homologous to the promoter and terminator region of ADE1 in S. paradoxus. C. Potential replacements of 
URA3 with ade1-14 for both S. bayanus and S. paradoxus were checked on a 1% agarose gel. (*) marks a 
potential in S. bayanus which proved to be a correct replacement after sequencing. (**) is a potential in S. 
paradoxus that contains the ade1-14 allele. However, it contains two amino acid substitutions (accidentally 
introduced by PCR) when compared to the sequence of ade1-14 from S. cerevisiae. D. DNA sequence of 
the S. paradoxus (**) potential. The premature stop codon is indicated by red capital letters. The 
substitutions compared to ade1-14 from S. cerevisiae are marked in lower-case red letter. Both 


















] strains, and from S. paradoxus and S. bayanus after growing the strains overnight 
in liquid YPD. The total lysate (T) was centrifuged at 53,000 g for 30 minutes to obtain supernatant (S) and 





 nitrocellulose membrane. The proteins were detected with a rabbit primary antibody to 















Figure 8. HPR6.6-fusion constructs used for [PSI
+
] induction. A. Sup35NM from S. cerevisiae, S. 
paradoxus and S. bayanus were each fused to a part of the Human Progesterone Receptor 6.6 protein 
(HPR6.6). B. Actual amino acid sequence (one-letter code) of HPR6.6 that was used in the fusion 
constructs. C. A simplified scheme for the shuffle plasmids used for the expression of the SUP35NM-
HPR6.6 constructs. The plasmids contained the SUP35NM-HPR6.6 fusions under the control of the 
inducible CUP1 promoter (PCUP1). URA3 and ampicillin-resistance (AMP
R
) genes were the selectable 








] induction in S. cerevisiae and S. bayanus. A. S. cerevisiae strains containing Sup35SC, 
Sup35SP or Sup35SB expressed from a plasmid with endogenous SUP35 promoter were induced to become 
[PSI
+
] by the overexpression of Sup35NM, Sup35NMSC-HPR6.6, Sup35NMSP-HPR6.6, Sup35NMSB-
HPR6.6, Sup35NMSP-GFP, or Sup35NMSB-GFP from the CUP1 copper-inducible promoter. 
Approximately 12 transformants for each combination were grown on media containing 100µM CuSO4 for 
two days and replica-plated to media lacking adenine. The pictures show representative transformants from 
media lacking adenine after growth with 100µM CuSO4 for 15 days. B. S. bayanus strains containing 
Sup35SC, Sup35SP or Sup35SB expressed from a plasmid with endogenous SUP35 promoter were induced to 
become [PSI
+
] by the overexpression of Sup35NMSC-HPR6.6, Sup35NMSP-HPR6.6 or Sup35NMSB-
HPR6.6 from the CUP1 copper-inducible promoter. A control experiment contained no inducer. 
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Approximately 12 transformants were grown on media containing 25µM CuSO4 for one day and replica-
plated to media lacking adenine. The pictures show representative transformants from media lacking 




















Figure 10. Expression of Sup35 and Sup35NMSC-HPR6.6 and Sup35NMSB-HPR6.6 inducers in S. 
cerevisiae and S. bayanus. The Sup35NMSC-HPR6.6 and Sup35NMSB-HPR6.6 inducers were expressed 
from the CUP1 copper-inducible promoter, while full-length Sup35 was expressed from its own SUP35 
promoter. Expression levels were checked by Western blot after strains containing the inducers and the 
full-length proteins were grown on media containing 0, 25 or 100µM CuSO4 for S. cerevisiae, and 0 and 
25µM CuSO4 for S. bayanus. The proteins were detected with a rabbit primary antibody to Sup35NM 















] induction in S. paradoxus. The wild-type chromosomal Sup35 from S. paradoxus was 
induced to become [PSI
+
] by the overexpression of Sup35NMSC-HPR6.6, Sup35NMSP-HPR6.6 or 
Sup35NMSB-HPR6.6 from the CUP1 copper-inducible promoter. A control experiment contained no 
inducer. Approximately 12 transformants were grown on media containing 25µM CuSO4 for one day and 
replica-plated to media lacking adenine. The pictures show representative transformants from media 













Figure 12. Sup35 aggregation in S. paradoxus. S. paradoxus strains before induction (Ade
-
), and after 
induction and loss of the inducing plasmid for a single Ade
+
 colony were each grown overnight in liquid 
YPD. The total proteins were isolated to obtain the total cell lysate (T). The total lysate was centrifuged at 
10,000 g for 15 minutes to separate the supernatant (S) and pellet (P). Each fraction was boiled in SDS, run 




 nitrocellulose membrane. The 
proteins were detected with a rabbit primary antibody to Sup35NM (1:2000 v/v dilution) and a rabbit HRP 















Figure 13. A model for the role of the Sup35NM-HPR6.6 fusion constructs in [PSI
+
] induction. The 
overexpression of Sup35NM-HPR6.6 and potentially the hydrophobicity of HPR6.6 itself could make the 
fusion constructs likely to aggregate in a prion-like state. This aggregated state could then act as a scaffold 
where Sup35 can bind and undergo the conformational change required for its conversion from non-prion, 
[psi
-
], isoform to prion [PSI
+
] isoform. After the prion conversion of Sup35, the [PSI
+
] aggregates and the 
















10. APPENDIX B: TABLES 
Table 1. List of Yeast Strains Used in This Study 
Strain 
Name* 
Genotype Used for 
Saccharomyces cerevisiae strains 
GT671 
MATα ade1-14 his3∆ (or 11,15) lys2 ura3-2 leu3,112  







MATα ade1-14 his3∆ (or 11,15) lys2 ura3-2 leu3,112  







MATα ade1-14 his3∆ (or 11,15) lys2 ura3-2 leu3,112  







MATα ade1-14 his3∆ (or 11,15) lys2 ura3-2 leu3,112  







MATα ade1-14 his3∆ (or 11,15) lys2 ura3-2 leu3,112  







MATα ade1-14 his3∆ (or 11,15) lys2 ura3-2 leu3,112  






Saccharomyces paradoxus strains 
GT983-2A MATa ura3-P2 lys2 ∆ho::KanMX6 Strain creation 
GT992 















Saccharomyces bayanus strains 




] Strain creation 




] Strain creation 




] Strain creation 




] Strain creation 
GT1131 
MATα ura3-1 ade1::ade1-14SC sup35∆::ClonNAT  







MATα ura3-1 ade1::ade1-14SC sup35∆::ClonNAT  







MATα ura3-1 ade1::ade1-14SC sup35∆::ClonNAT  






* All strains except Su1A were created for this study. Su1A was created by Talarek et al. (2004) 
 46 
Table 2. List of Primers Used in This Study  
Primer  
Name 
Number* Sequence Used for 




5’ CTGGGCCAAC CGCATCGGAA GCACTGCTTA 
 GAGGGATATC ATACAAAGAG AGAAGCAAGA  
ATGTCAATTA CGAAGACTGA 3’ 
Forward for amplifying ade1-
14SC with 60 bp upstream 





5’ TACGTATGTA TATATTTAGT GCGAGATTCA  
CTGATGACCT GTAACAAATA GAAAGAACGC 
TTAGTGAGAC CATTTAGACC 3’ 
Reverse for amplifying ade1-
14SC with 60 bp downstream 
homol. to ADE1SB terminator 
ADE1Sbay 
che-F 
378 5’ ATACAAAGAG AGAAGCAAGA 3’ 




379 5’ GTAACAAATAG AAAGAACGC 3’ 




444 5’ CTGGGCCAAC CGCATCGGAA 3’ 
Forward for sequencing ade1-




445 5’ TCTCAAGAGT TCCCAGAACC 3’ 
Forward for sequencing ade1-
14, starts at 450 bp of ORF 
ADE1-14-
SB-R+470 
446 5’ GGTTCTGGGA ACTCTTGAGA 3’ 
Reverse for sequencing ade1-
14, starts at 470 bp of ORF 
ADE1-14-
SB-R+980 
447 5’ TACGTATGTA TATATTTAGT 3’ 
Reverse for sequencing ade1-




5’ GTTTACTAGC AACAGTACCT ATACCTGCCC  
ACTAGTAATC GGATCCCCGG GTTAATTAAG 3’ 
Amplifying ClonNAT gene, with 




5’ TGGGGTTGTT TTTTTTTTTC GTTTAATTCT  
TGCGAAAAA AGAGCTCGAT TACAACAGGTG 
3’ 
Amplifying ClonNAT gene, with 




534 5’ ATACCTGCCCA CTAGCAATC 3’ 





533 5’ GTTTAATTCT TGCGAAAAAA 3’ 
Reverse for checking sup35∆ 
potentials 




5’ AGAATCAATT GAATCATAAG CATTACTTAT 
AAAGAATACA CATACGAAAA GTAATAACAA 
TGTCAATTAC GAAGACTGA 3’ 
Forward for amplifying ade1-
14SC with 60 bp upstream 





5’ ATGTATGATT CATATTTAGT GCGAAGTACA  
CTGGCGACTT GTAGCATATG TAAAAACACT  
TTAGTGAGAC CATTTAGACC 3’ 
Reverse for amplifying ade1-
14SC with 60 bp downstream 






5’ TATATATATAT GTACATTCTC ACCTGGATTC 
TTTGGGGGTA AAACGGTTGA GTGTTGTGCT 
TTTGTAGTTG GTACTGTTAA GAATCAATTG 
AATCATAA G 3’ 
Forward for amplifying ade1-
14SC with 140 bp upstream 
homol. to ADE1SP promoter. 






5’ CGCCAAACCT GCATACCACT 
GGCAAACAAG 
ATATCGATAA GACTTGCTTT GAGAACATTT 
ATACATTAAT ACATATGGGT ATGTATGATT 
CATATTTAG T 3’ 
Reverse for amplifying ade1-
14SC with 140 bp downstream 
hom. to ADE1SP terminator. 




392 5’ CATACGAAAA AGTAATAACA 3’ 




393 5’ GTAGCATATG TAAAAACACT 3’ 
Reverse for checking ade1-14  
potentials 
ADE1-F-1 473 5’ ATGTCAATTA CGAAGACTGA 3’ 
Forward for sequencing ade1-
14, starts at position 1 of ORF 
ADE1-R-
920 
476 5’ TAGTGAGACC ATTTAGACCC 3’ 
Reverse for sequencing ade1-
14, starts position 920 of ORF 
ADE1-14-
SB-F+450 
445 5’ TCTCAAGAGT TCCCAGAACC 3’ 
Forward for sequencing ade1-
14, starts at 450 bp of ORF 
ADE1-14-
SB-R+470 
446 5’ GGTTCTGGGA ACTCTTGAGA 3’ 
Reverse for sequencing ade1-
14, starts at 470 bp of ORF 
ade1-14-F 
-700 
567 5’ AGGTGCTAAC GCCAGACTCC 3’ 
Forward for sequencing ade1-




566 5’ GGAGTCTGGC GTTAGCACCT 3’ 
Reverse for sequencing ade1-
14, starts position 720 of ORF 
* Number of primer as entered in lab collection  












Table 3. List of Plasmids Used in This Study 





pYCL-CUP-NMSc PCUP1 SUP35NMSC LEU2 
pYCL-CUP-NMScHPR6.6 PCUP1 SUP35NMSC LEU2 
PmCUPs-Sup35NMSpar-HPR6.6 PCUP1 SUP35NMSP URA3 
PmCUPs-Sup35NMSpar-sGFP#2 PCUP1 SUP35NMSP URA3 
PmCUPs-Sup35NMSbay-HPR6.6 PCUP1 SUP35NMSB URA3 
PmCUPs-Sup35NMSbay-sGFP#2 PCUP1 SUP35NMSB URA3 
pRS316-CUP-SUP35NM-HPR6.6 PCUP1 SUP35NMSC URA3 
pRS316-GAL** PGAL1 None URA3 
* All plasmids are centromeric 


















Table 4. Stability and strength of the induced prions in different cell environments 


















Sup35SB No No Yes Unstable Weak 





Sup35SC No No No N/A N/A 
Sup35SP No No No N/A N/A S. bayanus 
Sup35SB No No No N/A N/A 
* The inducers are the HPR6.6-fusion constructs of Sup35NM   
 
